PEDIATRICS Vol. 96 No. 2 August 1995, pp. 239-246
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Assouline, L.
Right arrow Articles by Lambert, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Assouline, L.
Right arrow Articles by Lambert, M.

Familial Hypercholesterolemia: Molecular, Biochemical, and Clinical Characterization of a French-Canadian Pediatric Population

Linda Assouline BSc1, Emile Levy Ph.D2, Juan Carlos Feoli-Fonseca MD3, Caroline Godbout MSc4, and Marie Lambert MD3

1 Department of Nutrition, Hôpital Sainte-Justine and Université de Montréal, Québec, Canada
2 Department of Nutrition, Hôpital Sainte-Justine and Université de Montréal, Québec Canada
3 Department of Pediatrics, Hôpital Sainte-Justine and Université de Montréal, Québec, Canada
4 Department of Mathematics and Statistics, Université de Montréal, Québec, Canada

Background. Familial hypercholesterolemia (FH) is a dominantly-inherited disorder attributable to a defect in the low-density lipoprotein (LDL) receptor gene. Five mutations at this locus have been identified in French-Canadians. In children, it may be difficult to clinically distinguish FH from other forms of polygenic or monogenic hyperlipidemia. Therefore, our objectives were to define the molecular basis of our subjects' hypercholesterolemia, to characterize their biochemical phenotype in relation to the underlying molecular defect, and to assess their response to chronic dietary therapy.

Methods. We studied 88 unrelated French-Canadian children with a persistent increase in LDL cholesterol and a parental history of hyperlipidemia. Baseline and end-of-diet lipid and apolipoprotein levels were measured. Mutational analysis at the LDL receptor gene locus was performed.

Results. Heterozygosity for the common French-Canadian LDL receptor gene >10-kb deletion was found in 57% of subjects (group 1), 14% carried one of the other four previously characterized LDL receptor gene mutations (group 2), and none of the five molecular defects tested was detected in 29% (group 3). Total cholesterol, LDL cholesterol, and apolipoprotein B baseline levels were similar among these three groups but significantly higher than in control subjects. However, there was wide interindividual variability even among those carrying the same mutation. Significantly lower baseline levels of high-density lipoprotein cholesterol and apolipoprotein A1 were found in group 1 compared with group 3 and the controls. The response to diet was similar among the three groups with an average reduction in the mean level of total cholesterol of 4.4%.

Conclusions. The frequency of proven FH heterozygotes (71%) was remarkable in the pediatric population studied. Our data suggest that, in children, a persistent primary increase in LDL cholesterol associated with a parental history of hyperlipidemia is a good predictor of an underlying monogenic disorder as opposed to a polygenic disorder, at least in French-Canadians. Only molecular analysis allowed us to unequivocally define the cause of our patients' hypercholesterolemia. Most children with familial hyperlipidemia did not reach desirable plasma lipid levels solely under diet therapy.

Submitted on August 2, 1994
Accepted on November 18, 1994




This article has been cited by other articles:


Home page
 J. Am. Coll. Nutr.Home page
T. Gulesserian and K. Widhalm
Effect of a Rapeseed Oil Substituting Diet on Serum Lipids and Lipoproteins in Children and Adolescents with Familial Hypercholesterolemia
J. Am. Coll. Nutr., April 1, 2002; 21(2): 103 - 108.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
M. Lambert, L. Assouline, J. C. Feoli-Fonseca, N. Brun, E. E. Delvin, and E. Levy
Determinants of Lipid Level Variability in French-Canadian Children With Familial Hypercholesterolemia
Arterioscler. Thromb. Vasc. Biol., June 1, 2001; 21(6): 979 - 984.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
A. F. Vuorio, H. Turtola, and K. Kontula
Neonatal Diagnosis of Familial Hypercholesterolemia in Newborns Born to a Parent With a Molecularly Defined Heterozygous Familial Hypercholesterolemia
Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 3332 - 3337.
[Abstract] [Full Text]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
S. N. Pimstone, J. C. Defesche, S. M. Clee, H. D. Bakker, M. R. Hayden, and J. J.P. Kastelein
Differences in the Phenotype Between Children With Familial Defective Apolipoprotein B-100 and Familial Hypercholesterolemia
Arterioscler. Thromb. Vasc. Biol., May 1, 1997; 17(5): 826 - 833.
[Abstract] [Full Text]